Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Targeting the Paracrine Hormone-Dependent Guanylate cyclase/cGMP/Phosphodiesterases Signaling Pathway for Colorectal Cancer Prevention.

Yarla NS, Gali H, Pathuri G, Smriti S, Madka V, Panneerselvam J, Kumar G, Farooqui M, Rao CV.

Semin Cancer Biol. 2018 Sep 3. pii: S1044-579X(18)30064-6. doi: 10.1016/j.semcancer.2018.08.011. [Epub ahead of print] Review.

PMID:
30189250
2.

Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer.

Miranda O, Farooqui M, Siegfried JM.

Cancers (Basel). 2018 Aug 21;10(9). pii: E280. doi: 10.3390/cancers10090280. Review.

3.

Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: A systematic review and meta-analysis.

Farooqui MA, Elsayed Y, Jeyaraman MM, Dingwall O, Tagin M, Zarychanski R, Rabbani R, Abou-Setta AM.

J Neonatal Perinatal Med. 2018 Jul 19. doi: 10.3233/NPM-17130. [Epub ahead of print]

PMID:
30040749
4.

A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan.

Hussain R, Hassali MA, Hashmi F, Farooqui M.

J Pharm Policy Pract. 2018 Jul 19;11:16. doi: 10.1186/s40545-018-0143-0. eCollection 2018.

5.

Recent update on basic mechanisms of spinal cord injury.

Quadri SA, Farooqui M, Ikram A, Zafar A, Khan MA, Suriya SS, Claus CF, Fiani B, Rahman M, Ramachandran A, Armstrong IIT, Taqi MA, Mortazavi MM.

Neurosurg Rev. 2018 Jul 11. doi: 10.1007/s10143-018-1008-3. [Epub ahead of print] Review.

PMID:
29998371
6.

Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.

Taneja A, Jones J, Pittaluga S, Maric I, Farooqui M, Ahn IE, Wiestner A, Sun C.

Leuk Lymphoma. 2018 Jul 6:1-4. doi: 10.1080/10428194.2018.1480775. [Epub ahead of print] No abstract available.

PMID:
29978754
7.

Spontaneous development of Alzheimer's disease-associated brain pathology in a Shugoshin-1 mouse cohesinopathy model.

Rao CV, Farooqui M, Zhang Y, Asch AS, Yamada HY.

Aging Cell. 2018 Jun 25:e12797. doi: 10.1111/acel.12797. [Epub ahead of print]

8.

STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer.

Njatcha C, Farooqui M, Kornberg A, Johnson DE, Grandis JR, Siegfried JM.

Mol Cancer Ther. 2018 Sep;17(9):1917-1926. doi: 10.1158/1535-7163.MCT-17-1194. Epub 2018 Jun 11.

PMID:
29891486
9.

Intercalated Disk Extracellular Nanodomain Expansion in Patients With Atrial Fibrillation.

Raisch TB, Yanoff MS, Larsen TR, Farooqui MA, King DR, Veeraraghavan R, Gourdie RG, Baker JW, Arnold WS, AlMahameed ST, Poelzing S.

Front Physiol. 2018 May 4;9:398. doi: 10.3389/fphys.2018.00398. eCollection 2018.

10.

Anatomical Variability of the Posterior Communicating Artery.

Gunnal SA, Farooqui MS, Wabale RN.

Asian J Neurosurg. 2018 Apr-Jun;13(2):363-369. doi: 10.4103/ajns.AJNS_152_16.

11.

Impact of robot-assisted spine surgery on health care quality and neurosurgical economics: A systemic review.

Fiani B, Quadri SA, Farooqui M, Cathel A, Berman B, Noel J, Siddiqi J.

Neurosurg Rev. 2018 Apr 3. doi: 10.1007/s10143-018-0971-z. [Epub ahead of print] Review.

PMID:
29611081
12.

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, Marti GE, Pittaluga S, Herman SEM, Niemann CU, Pedersen LB, Geisler CH, Childs R, Aue G, Wiestner A.

Blood. 2018 May 24;131(21):2357-2366. doi: 10.1182/blood-2017-12-820910. Epub 2018 Feb 26.

PMID:
29483101
13.

Alport's syndrome with focal segmental glomerulosclerosis lesion - Pattern to recognize.

Alsahli AA, Alshahwan SI, Alotaibi AO, Alsaad KO, Aloudah N, Farooqui M, Al Sayyari AA.

Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):167-172. doi: 10.4103/1319-2442.225193.

14.

Women's perspectives towards traditional and complementary medicine used to conceive, during pregnancy and the postpartum period.

Shaukat Ali R, Gnanasan S, Farooqui M.

Complement Ther Clin Pract. 2018 Feb;30:109-115. doi: 10.1016/j.ctcp.2017.12.009. Epub 2017 Dec 22.

PMID:
29389469
15.

High-intensity focused ultrasound: past, present, and future in neurosurgery.

Quadri SA, Waqas M, Khan I, Khan MA, Suriya SS, Farooqui M, Fiani B.

Neurosurg Focus. 2018 Feb;44(2):E16. doi: 10.3171/2017.11.FOCUS17610.

PMID:
29385923
16.

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.

Landau DA, Sun C, Rosebrock D, Herman SEM, Fein J, Sivina M, Underbayev C, Liu D, Hoellenriegel J, Ravichandran S, Farooqui MZH, Zhang W, Cibulskis C, Zviran A, Neuberg DS, Livitz D, Bozic I, Leshchiner I, Getz G, Burger JA, Wiestner A, Wu CJ.

Nat Commun. 2017 Dec 19;8(1):2185. doi: 10.1038/s41467-017-02329-y.

17.

Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study.

Zafar A, Ikram A, Jillella DV, Kempuraj D, Khan MM, Bushnaq S, Adam H, Ortega-Gutierrez S, Quadri SA, Farooqui M, Zaheer A, Leira EC.

Cureus. 2017 Oct 11;9(10):e1767. doi: 10.7759/cureus.1767.

18.

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.

Stabile LP, Farooqui M, Kanterewicz B, Abberbock S, Kurland BF, Diergaarde B, Siegfried JM.

J Thorac Oncol. 2018 Mar;13(3):399-412. doi: 10.1016/j.jtho.2017.11.126. Epub 2017 Dec 9.

PMID:
29233790
19.

Knowledge, Attitude and Practices Regarding Benign Testicular Disorders in the Educated Young Men of Pakistan.

Saleem D, Muneer S, Younus Khan RF, Ochani RK, Ahmed SS, Begg M, Siddiqi TJ, Abbas SR, Naseeb MW, Farooqui MO, Shaikh FH, Kirmani R, Ullah H, Fatima K.

Cureus. 2017 Aug 13;9(8):e1563. doi: 10.7759/cureus.1563.

20.

Research Associates Program: Expanding clinical research productivity with undergraduate students.

Hoonpongsimanont W, Sahota PK, Ng NN, Farooqui MJ, Chakravarthy B, Patel B, Lotfipour S.

SAGE Open Med. 2017 Sep 11;5:2050312117730245. doi: 10.1177/2050312117730245. eCollection 2017.

21.

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.

Rao CV, Pal S, Mohammed A, Farooqui M, Doescher MP, Asch AS, Yamada HY.

Oncotarget. 2017 May 10;8(34):57605-57621. doi: 10.18632/oncotarget.17745. eCollection 2017 Aug 22. Review.

22.

Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.

Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.

Am J Emerg Med. 2018 Jan;36(1):88-92. doi: 10.1016/j.ajem.2017.07.037. Epub 2017 Jul 13.

PMID:
28802541
23.

Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for Cannabinoid Dependency and Persistent Vomiting.

Al-Shammari M, Herrera K, Liu X, Gisi B, Yamashita T, Han KT, Azab M, Mashiana H, Maklad M, Farooqui MT, Makar R, Yoo JW.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1876-1881. doi: 10.1016/j.cgh.2017.06.055. Epub 2017 Jul 12.

PMID:
28711691
24.

Posttraumatic stress disorder: a serious post-earthquake complication.

Farooqui M, Quadri SA, Suriya SS, Khan MA, Ovais M, Sohail Z, Shoaib S, Tohid H, Hassan M.

Trends Psychiatry Psychother. 2017 Apr-Jun;39(2):135-143. doi: 10.1590/2237-6089-2016-0029. Review.

25.

Transradial vs. Transfemoral Approach in Cardiac Catheterization: A Literature Review.

Anjum I, Khan MA, Aadil M, Faraz A, Farooqui M, Hashmi A.

Cureus. 2017 Jun 3;9(6):e1309. doi: 10.7759/cureus.1309. Review.

26.

Opioids and opioid receptors orchestrate wound repair.

Wang Y, Gupta M, Poonawala T, Farooqui M, Li Y, Peng F, Rao S, Ansonoff M, Pintar JE, Gupta K.

Transl Res. 2017 Jul;185:13-23. doi: 10.1016/j.trsl.2017.05.003. Epub 2017 May 18.

27.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Tarhini AA, Rafique I, Floros T, Tran P, Gooding WE, Villaruz LC, Burns TF, Friedland DM, Petro DP, Farooqui M, Gomez-Garcia J, Gaither-Davis A, Dacic S, Argiris A, Socinski MA, Stabile LP, Siegfried JM.

Cancer. 2017 Aug 1;123(15):2936-2944. doi: 10.1002/cncr.30717. Epub 2017 May 4.

28.

Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.

Siegfried JM, Farooqui M, Rothenberger NJ, Dacic S, Stabile LP.

Oncotarget. 2017 Apr 11;8(15):24063-24076. doi: 10.18632/oncotarget.16030.

29.

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU.

Leuk Lymphoma. 2017 Oct;58(10):2356-2362. doi: 10.1080/10428194.2017.1285027. Epub 2017 Feb 7.

PMID:
28278728
30.

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors.

Albitar A, Ma W, DeDios I, Estella J, Ahn I, Farooqui M, Wiestner A, Albitar M.

Oncotarget. 2017 Mar 14;8(11):17936-17944. doi: 10.18632/oncotarget.15316.

31.

Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.

Kanshana JS, Khanna V, Singh V, Jain M, Misra A, Kumar S, Farooqui M, Barthwal MK, Dikshit M.

J Cardiovasc Pharmacol. 2017 May;69(5):314-325. doi: 10.1097/FJC.0000000000000477.

PMID:
28207427
32.

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.

Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, Tian X, Hughes TE, Sun C, Arthur DC, Stetler-Stevenson M, Yuan CM, Niemann CU, Marti GE, Aue G, Soto S, Farooqui MZH, Herman SEM, Chiorazzi N, Wiestner A.

Leukemia. 2017 Jun;31(6):1340-1347. doi: 10.1038/leu.2017.11. Epub 2017 Jan 11.

33.

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, Arthur DC, Wake L, Pittaluga S, Yuan CM, Stetler-Stevenson M, Soto S, Valdez J, Nierman P, Lotter J, Xi L, Raffeld M, Farooqui M, Albitar M, Wiestner A.

Blood. 2017 Mar 16;129(11):1469-1479. doi: 10.1182/blood-2016-06-719294. Epub 2017 Jan 3.

34.

Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.

Khan FA, Zaheer Z, Sangshetti JN, Patil RH, Farooqui M.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):567-573. doi: 10.1016/j.bmcl.2016.12.018. Epub 2016 Dec 8.

PMID:
28003139
35.

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.

Sun C, Gao J, Couzens L, Tian X, Farooqui MZ, Eichelberger MC, Wiestner A.

JAMA Oncol. 2016 Dec 1;2(12):1656-1657. doi: 10.1001/jamaoncol.2016.2437. No abstract available.

PMID:
27533065
36.

Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib.

Ahn IE, Jerussi T, Farooqui M, Tian X, Wiestner A, Gea-Banacloche J.

Blood. 2016 Oct 13;128(15):1940-1943. Epub 2016 Aug 8.

37.

Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.

Saleh LM, Wang W, Herman SE, Saba NS, Anastas V, Barber E, Corrigan-Cummins M, Farooqui M, Sun C, Sarasua SM, Zhao Z, Abousamra NK, Elbaz O, Abdelghaffar HA, Wiestner A, Calvo KR.

Leukemia. 2017 Feb;31(2):340-349. doi: 10.1038/leu.2016.181. Epub 2016 Jun 24.

PMID:
27431016
38.

Sound attenuation in ducts using locally resonant periodic aluminum patches.

Farooqui M, Elnady T, Akl W.

J Acoust Soc Am. 2016 Jun;139(6):3277. doi: 10.1121/1.4948990.

PMID:
27369152
39.

Validation of low frequency noise attenuation using locally resonant patches.

Farooqui M, Elnady T, Akl W.

J Acoust Soc Am. 2016 Jun;139(6):3267. doi: 10.1121/1.4950736.

PMID:
27369151
40.

Low Cost Inkjet Printed Smart Bandage for Wireless Monitoring of Chronic Wounds.

Farooqui MF, Shamim A.

Sci Rep. 2016 Jun 29;6:28949. doi: 10.1038/srep28949.

41.

Low frequency sound attenuation in a flow duct using a thin slow sound material.

Aurégan Y, Farooqui M, Groby JP.

J Acoust Soc Am. 2016 May;139(5):EL149. doi: 10.1121/1.4951028.

PMID:
27250200
42.

Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.

Vitale C, Ahn IE, Sivina M, Ferrajoli A, Wierda WG, Estrov Z, Konoplev SN, Jain N, O'Brien S, Farooqui M, Keating MJ, Wiestner A, Burger JA.

Haematologica. 2016 Jun;101(6):e254-8. doi: 10.3324/haematol.2015.138289. Epub 2016 Mar 24. No abstract available.

43.

Rights and Responsibilities of Tuberculosis Patients, and the Global Fund: A Qualitative Study.

Atif M, Javaid S, Farooqui M, Sarwar MR.

PLoS One. 2016 Mar 21;11(3):e0151321. doi: 10.1371/journal.pone.0151321. eCollection 2016.

44.

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.

Bitar C, Farooqui MZ, Valdez J, Saba NS, Soto S, Bray A, Marti G, Wiestner A, Cowen EW.

JAMA Dermatol. 2016 Jun 1;152(6):698-701. doi: 10.1001/jamadermatol.2016.0225.

PMID:
26982511
45.

Utility of indium-111 octreotide to identify a cardiac metastasis of a carcinoid neoplasm.

Farooqui M, Rathore S, Ball T.

Proc (Bayl Univ Med Cent). 2016 Jan;29(1):76-8.

46.

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.

Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Wong DH, Jones J, Sun C, Marti GE, Farooqui MZ, Wiestner A.

Clin Cancer Res. 2016 Apr 1;22(7):1572-82. doi: 10.1158/1078-0432.CCR-15-1965. Epub 2015 Dec 9.

47.

KAP AMONG DOCTORS WORKING IN HOSPITALS, REGARDING HALAL PHARMACEUTICALS; A CROSS SECTIONAL ASSESSMENT.

Sadeeqa S, Sarriff A, Masood I, Atif M, Farooqui M.

Acta Pol Pharm. 2015 May-Jun;72(3):615-24.

48.

Purpose, Belief And Rate of Disclosure of Cam Use Among Diabetic Patients In Quetta, Pakistan.

Ul Haq N, Saeed S, Iqbal Q, Naseem A, Razaq G, Farooqui M.

Value Health. 2015 Nov;18(7):A865-6. doi: 10.1016/j.jval.2015.09.517. Epub 2015 Oct 20. No abstract available.

49.

Use of Complementary And Alternative Medicines (Cam) In Diabetics Patients In Quetta.

Ul Haq N, Saeed S, Iqbal Q, Naseem A, Razaq G, Farooqui M.

Value Health. 2015 Nov;18(7):A865. doi: 10.1016/j.jval.2015.09.516. Epub 2015 Oct 20. No abstract available.

50.

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.

Lipsky AH, Farooqui MZ, Tian X, Martyr S, Cullinane AM, Nghiem K, Sun C, Valdez J, Niemann CU, Herman SE, Saba N, Soto S, Marti G, Uzel G, Holland SM, Lozier JN, Wiestner A.

Haematologica. 2015 Dec;100(12):1571-8. doi: 10.3324/haematol.2015.126672. Epub 2015 Oct 1.

Supplemental Content

Loading ...
Support Center